Dolby Laboratories Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Dolby Laboratories wird ein Gewinn- und Umsatzwachstum von 17.6% bzw. 5.6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 22% pro Jahr wachsen soll.

Wichtige Informationen

13.7%

Wachstumsrate der Gewinne

15.6%

EPS-Wachstumsrate

Software Gewinnwachstum15.8%
Wachstumsrate der Einnahmen5.5%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert20 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 05
Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Sep 22
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital

Aug 22

Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion

Aug 13
Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion

We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)

Jul 26
We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)

Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation

Jun 10

Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?

Jun 07
Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?

Dolby Laboratories Remains A Hold

May 14

Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 05
Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors

May 02
Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors

Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist

Apr 16
Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist

Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate

Mar 17
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate

Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)

Mar 01

Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye

Feb 09
Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Jan 31
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For

Jan 15
With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For

The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising

Dec 28
The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising

Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue

Dec 06

A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Nov 18
A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)

At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?

Oct 11
At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?

Dolby Laboratories: High P/E Is Not Justified, A Hold For Now

Sep 13

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

Aug 03
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Jul 12
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Dolby Laboratories Sees Return To Growth Ahead

Jun 22

Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture

May 04
Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture

A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Apr 14
A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Mar 29
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

Dolby Laboratories goes ex-dividend on Monday

Feb 10

Dolby Laboratories FQ1 2023 Earnings Preview

Feb 01

Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company

Jan 24
Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company

Dolby: A 2023 Update, And Still A 'Hold'

Jan 11

An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued

Jan 09
An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued

Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?

Dec 25
Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?

Gewinn- und Umsatzwachstumsprognosen

NYSE:DLB - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
9/30/20261,443299N/AN/A1
9/30/20251,334263N/AN/A3
9/30/20241,277241280N/A3
6/28/20241,259212265296N/A
3/29/20241,269190365396N/A
12/29/20231,280188290319N/A
9/29/20231,300201337367N/A
6/30/20231,287219301333N/A
3/31/20231,279242348385N/A
12/30/20221,237183303343N/A
9/30/20221,254184259319N/A
7/1/20221,261201316377N/A
4/1/20221,258216314377N/A
12/31/20211,243255332397N/A
9/24/20211,281310393448N/A
6/25/20211,267293398451N/A
3/26/20211,228306359413N/A
12/25/20201,260318334395N/A
9/25/20201,162231275344N/A
6/26/20201,189248287362N/A
3/27/20201,245221234319N/A
12/27/20191,231206195302N/A
9/27/20191,242255214328N/A
6/28/20191,183238194309N/A
3/29/20191,096201253360N/A
12/28/20181,057193307392N/A
9/28/20181,05542267352N/A
6/29/20181,05637236321N/A
3/30/20181,147110N/A317N/A
12/29/20171,11595N/A324N/A
9/29/20171,080206N/A378N/A
6/30/20171,072204N/A370N/A
3/31/20171,044192N/A359N/A
12/30/20161,051208N/A360N/A
9/30/20161,026186N/A360N/A
7/1/20161,025208N/A367N/A
4/1/2016980180N/A288N/A
1/1/2016977171N/A373N/A
9/25/2015971181N/A309N/A
6/26/2015965181N/A316N/A
3/27/2015956185N/A360N/A
12/26/2014963203N/A288N/A
9/26/2014960206N/A362N/A
6/27/2014950206N/A339N/A
3/28/2014934196N/A332N/A
12/27/2013904182N/A286N/A
9/27/2013910189N/A277N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: DLBDas prognostizierte Gewinnwachstum (17.6% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: DLBDie Erträge des Unternehmens (14% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.7% pro Jahr).

Hohe Wachstumserträge: DLBDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: DLBDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: DLBDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von DLB in 3 Jahren voraussichtlich hoch sein wird


Wachstumsunternehmen entdecken